{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:40:59Z","timestamp":1759639259769,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015613","name":"CHU Lille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.fjurol.2025.102930","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:16:10Z","timestamp":1753370170000},"page":"102930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prescribing androgen deprivation therapy for prostate cancer: Results of a French questionnaire survey"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9566-2780","authenticated-orcid":false,"given":"Th\u00e9ophile","family":"Pajot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5409-2911","authenticated-orcid":false,"given":"Jonathan","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"S\u00e9guier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnauld","family":"Villers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Penel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.fjurol.2025.102930_bib0045","first-page":"35","article-title":"Androgen action in the prostate gland","volume":"64","author":"Yadav","year":"2012","journal-title":"Minerva Urol Nefrol"},{"issue":"1","key":"10.1016\/j.fjurol.2025.102930_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/aps.2014.18","article-title":"Androgen receptor: structure, role in prostate cancer and drug discovery","volume":"36","author":"Tan","year":"2015","journal-title":"Acta Pharmacol Sin"},{"issue":"15","key":"10.1016\/j.fjurol.2025.102930_bib0055","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.purol.2022.07.147","article-title":"French AFU Cancer Committee Guidelines\u00a0\u2013\u00a0Update 2022\u20132024: prostate cancer\u00a0\u2013\u00a0Management of metastatic disease and castration resistance","volume":"32","author":"Ploussard","year":"2022","journal-title":"Prog Urol"},{"issue":"15","key":"10.1016\/j.fjurol.2025.102930_bib0060","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.purol.2022.07.148","article-title":"French AFU Cancer Committee Guidelines\u00a0\u2013\u00a0Update 2022\u20132024: prostate cancer\u00a0\u2013\u00a0Diagnosis and management of localised disease","volume":"32","author":"Ploussard","year":"2022","journal-title":"Prog Urol"},{"issue":"2","key":"10.1016\/j.fjurol.2025.102930_bib0065","first-page":"F53","article-title":"Comment je prescris une hormonoth\u00e9rapie intensifi\u00e9e?","volume":"33","author":"Pignot","year":"2023","journal-title":"Prog FMC"},{"key":"10.1016\/j.fjurol.2025.102930_bib0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.lpm.2011.04.001","article-title":"La vitamine D chez l\u2019adulte. recommandations du GRIO","volume":"40","author":"Benhamou","year":"2011","journal-title":"Press Med"},{"issue":"3","key":"10.1016\/j.fjurol.2025.102930_bib0075","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endrev\/bnab002","article-title":"Hormonal Therapy for Prostate Cancer","volume":"42","author":"Desai","year":"2021","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.fjurol.2025.102930_bib0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393025000774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393025000774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:58:12Z","timestamp":1759636692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950393025000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2950393025000774"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2025.102930","relation":{},"ISSN":["2950-3930"],"issn-type":[{"type":"print","value":"2950-3930"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing androgen deprivation therapy for prostate cancer: Results of a French questionnaire survey","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2025.102930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102930"}}